Premaitha Health PLC (LSE:NIPT) - Share price - Overview

Stock Report

Premaitha Health PLC NIPT

Last Price
GBX5.67

Day Change
0.04|0.80%

As of 11/12/2017
09:10:11 GMT | GBX
Minimum 15 Minutes Delay.

Last Close5.63p
Day Range5.50 - 5.97
Mkt Cap18.07Mil
52-Wk Range5.01 - 14.40
Yield %0.00
ISINGB00BN31ZD89
Volume635,092
P/E-2.10
P/S4.35
P/CF-1.70

Share Price

Total Returns 08/12/2017

 Chg (%)  
More ...
Premaitha Health PLC-29.69 
FTSE 100 TR GBP-1.38
 
Financials
201520162017
More ...
Income Statement
Turnover0.122.453.08
Operating Profit-6.95-12.03-7.60
Net Profit-6.87-12.08-7.86
Reported EPS-4.61-6.00-3.00
Balance Sheet
Current Assets4.308.566.12
Non Current Assets1.351.9411.44
Total Assets5.6510.4917.56
Current Liabilities1.597.486.94
Total Liabilities1.759.0011.72
Total Equity3.901.495.85
Cash Flow
Operating Cash Flow-4.87-7.04-7.86
Net Change in Cash2.452.63-4.04
Broker Forecasts
Year EndingPre-taxEPSEPSgP/EPEGDPSYld %
More ...
'Broker Forecasts' provides consensus figures based on several brokers' views
2018-4.26-1.33--4.23---
20193.381.00-5.63---

Company Profile

Premaitha Health PLC is a molecular diagnostics company. The company has developed IONA test that enables clinical laboratories to establish a routine, quality assured non-invasive prenatal screening service in-house.

Sector

Diagnostics & Research

Market Position

1369 of 1836 Companies

Index

FTSE AIM All Share

Outlook

(29/09/2017) no outlook statement

Next Event 21/12/2017

Next interim announcement
Ratios
CompSecMkt
More ...
PER (E)20.1913.1516.12
Div Yld (E)0.004.224.21
PEG (E)0.003.061.77
ROCE-315.90175.8613.28
Op Mrgn-226.05-8.542.92
EPS Grwth0.009.6912.22
Dividends
PreviousLatest
More ...
Record Datet.b.c.t.b.c.
Ex-Divt.b.c.t.b.c.
Paidt.b.c.t.b.c.
Amnt0.000.00

Broker Sentiment

Strong Buy0
Buy0
Hold0
Sell0
Strong Sell0
  • Strong Sell
  • Strong Buy
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
More ...
Disclaimer
Directors
More ...
Chief Executive OfficerDr. Stephen Little
Chief Financial Officer & Company SecretBarry Hextall
AJ Bell includes AJ Bell Holdings Limited and its wholly owned subsidiaries. AJ Bell Management Limited and AJ Bell Securities Limited are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.
© Copyright 2017 Morningstar. All rights reserved.